NAFLD: An Emerging Causal Factor for Cardiovascular Disease.

Area of Science:

• Hepatology and Cardiology
• Metabolic Syndrome Research

Background:

• Nonalcoholic fatty liver disease (NAFLD) is a global health concern.
• Cardiovascular disease (CVD) is the primary cause of death in NAFLD patients.
• Shared risk factors include obesity, insulin resistance, and type 2 diabetes.

Purpose of the Study:

• To review evidence supporting a causal link between NAFLD and CVD.
• To explore mechanisms connecting NAFLD to CVD development.
• To emphasize integrated management of NAFLD and CVD risk.

Main Methods:

• Analysis of prospective clinical studies.
• Evaluation of Mendelian randomization studies.
• Synthesis of current research on NAFLD-CVD pathogenesis.

Main Results:

• Evidence suggests NAFLD may be a causal risk factor for CVD.
• Mechanisms involve shared metabolic pathways and direct liver-to-heart effects.
• Clinical management requires concurrent attention to CVD risk in NAFLD patients.

Conclusions:

• NAFLD is increasingly recognized as a significant contributor to CVD.
• Understanding the causal relationship is crucial for patient outcomes.
• Integrated clinical strategies are essential for effective NAFLD and CVD management.